↓ Skip to main content

Dove Medical Press

Article Metrics

Clinical efficacy and safety of rituximab in lupus nephritis

Overview of attention for article published in Drug Design, Development and Therapy, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

blogs
1 blog
twitter
1 tweeter

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
40 Mendeley
Title
<p>Clinical efficacy and safety of rituximab in lupus nephritis</p>
Published in
Drug Design, Development and Therapy, March 2019
DOI 10.2147/dddt.s195113
Pubmed ID
Authors

Zhiqing Zhong, Hongyan Li, Hongzhen Zhong, Tianbiao Zhou

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 15%
Researcher 6 15%
Other 4 10%
Student > Postgraduate 4 10%
Student > Ph. D. Student 3 8%
Other 7 18%
Unknown 10 25%
Readers by discipline Count As %
Medicine and Dentistry 22 55%
Biochemistry, Genetics and Molecular Biology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Business, Management and Accounting 1 3%
Social Sciences 1 3%
Other 1 3%
Unknown 11 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2021.
All research outputs
#3,059,261
of 18,792,779 outputs
Outputs from Drug Design, Development and Therapy
#156
of 1,820 outputs
Outputs of similar age
#73,858
of 308,987 outputs
Outputs of similar age from Drug Design, Development and Therapy
#1
of 1 outputs
Altmetric has tracked 18,792,779 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,820 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 308,987 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them